4-羟基-3-硝基苯甲酰胺 | 70382-03-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 4-羟基-3-硝基苯甲酰胺
• 英文名称: 3-nitro-4-hydroxybenzamide
• 英文别名: 4-hydroxy-3-nitrobenzamide；4-hydroxy-3-nitro-benzamide；4-Hydroxy-3-nitrobenzamid
• CAS: 70382-03-5
• 化学式: C₇H₆N₂O₄
• 分子量: 182.136
• InChiKey: ZRSSXZYQEVYUAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  109
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-羟基-3-硝基苯甲酰胺 在 palladium 10% on activated carbon 环己烯 作用下， 以 乙醇 为溶剂， 反应 3.0h， 以57.2%的产率得到3-氨基-4-羟基-苯甲酰胺
  参考文献：
  名称：

  [EN] COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
  [FR] COMPOSÉS PRÉSENTANT UNE ACTIVITÉ AU NIVEAU DU RÉCEPTEUR M1 ET LEURS UTILISATIONS EN MÉDECINE

  摘要：

  提供具有公式(I)或其盐的化合物：其中R4、R5、R6、Q、A、Y和R按描述定义。披露了这些化合物作为药物的使用和在制造用于治疗精神病性障碍、认知障碍和阿尔茨海默病药物中的应用。本发明还公开了包含这些化合物的药物组合物。

  公开号：

  WO2009037294A1
• 作为产物：
  描述：

  4-羟基-3-硝基苯甲酸 在 ammonium hydroxide 、 二异丙胺 作用下， 以 二氯甲烷 为溶剂， 反应 48.0h， 生成 4-羟基-3-硝基苯甲酰胺
  参考文献：
  名称：

  Nonpeptide Inhibitors of Measles Virus Entry

  摘要：

  Measles virus (MV) is one of the most infectious pathogens known. Despite the existence of a vaccine, over 500 000 deaths/year result from MV or associated complications. Anti-measles compounds could conceivably reverse these statistics. Previously, we described a homology model of the MV fusion protein trimer and a putative binding site near the head-neck region. The resulting model permitted the identification of two nonpeptidic entry inhibitors. Here, we present the design, synthesis, and bioevaluation of several series of fusion inhibitors and describe their structure-activity relationships (SAR). Five simply substituted anilides show low-mu M blockade of the MV, one of which (AS-48) exhibits IC50 0.6-3.0 mu M across a panel of wild-type MV strains found in the field. Molecular field topology analysis (MFTA), a 2D QSAR approach based on local molecular properties (atomic charges, hydrogen-bonding capacity and local lipophilicity), applied to the anilide series suggests structural modifications to improve potency.

  DOI：

  10.1021/jm0602559
• 作为试剂：
  描述：

  3-硝基-4-羟基苯甲酸甲酯 、 ammonium hydroxide 在 4-羟基-3-硝基苯甲酰胺 、 水 作用下， 反应 168.0h， 生成 4-羟基-3-硝基苯甲酰胺
  参考文献：
  名称：

  BISTHIAZOLE INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

  摘要：

  本发明涉及双噻唑I及其治疗和预防用途，其中变量A、R5、R6和R7在规范中定义。治疗和/或预防的疾病包括类风湿性关节炎。

  公开号：

  US20120129842A1

文献信息

• [EN] TETRACYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM<br/>[FR] DERIVES DE PYRAZOLE TETRACYCLIQUE UTILISES COMME INHIBITEURS DE KINASE, PROCESSUS DE PREPARATION CORRESPONDANT ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT
  申请人：PHARMACIA ITALIA SPA

  公开号：WO2004071507A1

  公开（公告）日：2004-08-26

  The present invention provides a method for treating diseases caused by and/or associated with an altered protein kinase activity which comprises administering to a mammal in need thereof an effective amount of a tetracyclic pyrazole. The invention also provides specific tetracyclic pyrazole derivatives, useful intermediates, a library comprising at least two of them, a process for their preparation and the pharmaceutical compositions containing them, which are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, viral infections, autoimmune diseases and neurodegenerative disorders.

  本发明提供了一种治疗由改变的蛋白激酶活性引起和/或与之相关的疾病的方法，包括向需要的哺乳动物施用有效量的四环吡唑。该发明还提供了特定的四环吡唑衍生物、有用的中间体、包含至少两种中间体的库、它们的制备方法以及含有它们的药物组合物，这些药物组合物在治疗由改变的蛋白激酶活性引起和/或与之相关的疾病方面具有用处，如癌症、细胞增殖障碍、病毒感染、自身免疫疾病和神经退行性疾病。
• Use of Compounds for Inducing Differentiation of Mesenchymal Stem Cells to Chondrocytes
  申请人：Hwang Ki Chul

  公开号：US20130236969A1

  公开（公告）日：2013-09-12

  Use of a compound of Formula 1 for inducing differentiation of mesenchymal stem cells to chondrocytes, and a pharmaceutical composition for treating a cartilage disease, which includes chondrocytes in which differentiation from mesenchymal stem cells is induced by the compound of Formula 1, are provided. Differentiation of the mesenchymal stem cells treated with the compound of Formula 1 to chondrocytes is specifically induced, and thus the compound can be used to effectively treat a cartilage disease such as arthritis, cartilage damage, and a cartilage defect.

  提供一种使用公式1的化合物诱导间充质干细胞向软骨细胞分化的方法，以及用于治疗软骨疾病的制药组合物，其中包括由公式1的化合物诱导的间充质干细胞分化成的软骨细胞。经过公式1化合物处理的间充质干细胞被特异性地诱导分化成软骨细胞，因此该化合物可有效治疗软骨疾病，例如关节炎，软骨损伤和软骨缺陷。
• Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
  申请人：Vanotti Ermes

  公开号：US20060264493A1

  公开（公告）日：2006-11-23

  The present invention provides a method for treating diseases caused by and/or associated with an altered protein kinase activity which comprises administering to a mammal in need thereof an effective amount of a tetracyclic pyrazole. The invention also provides specific tetracyclic pyrazole derivatives, useful intermediates, a library comprising at least two of them, a process for their preparation and the pharmaceutical compositions containing them, which are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, viral infections, autoimmune diseases and neurodegenerative disorders.

  本发明提供了一种治疗由改变的蛋白激酶活性引起和/或相关的疾病的方法，包括向需要治疗的哺乳动物中给予有效量的四环吡唑。本发明还提供了特定的四环吡唑衍生物、有用的中间体、包含至少两个四环吡唑衍生物的库、它们的制备方法以及含有它们的药物组合物，这些组合物对于治疗由改变的蛋白激酶活性引起和/或相关的疾病，如癌症、细胞增殖性疾病、病毒感染、自身免疫性疾病和神经退行性疾病非常有用。
• Compounds which have activity at M1 receptor and their uses in medicine
  申请人：Cooper David Gwyn

  公开号：US20100204272A1

  公开（公告）日：2010-08-12

  Compounds of formula (I) or a salt thereof are provided: wherein R 4 , R 5 , R 6 , Q, A, Y and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders, cognitive impairments and Alzheimer's Disease are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.

  本发明提供了化学式(I)的化合物或其盐：其中R4，R5，R6，Q，A，Y和R的定义如说明书中所定义。本发明还揭示了将该化合物用作药物以及制造用于治疗精神障碍，认知障碍和阿尔茨海默病的药物的用途。本发明还揭示了包含该化合物的制药组合物。
• Compounds which have activity at M1receptor and their uses in medicine
  申请人：Glaxo Group Limited

  公开号：US08299257B2

  公开（公告）日：2012-10-30

  Compounds of formula (I) or a salt thereof are provided: wherein R4, R5, R6, Q, A, Y and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders, cognitive impairments and Alzheimer's Disease are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.

  本发明提供了公式（I）的化合物或其盐，其中R4，R5，R6，Q，A，Y和R如描述中所定义。揭示了将该化合物用作药物以及制造治疗精神疾病，认知障碍和阿尔茨海默病的药物的用途。本发明还揭示了包含该化合物的药物组合物。